Everest Medicines Overview
- Year Founded
-
2017
- Status
-
Public
- Employees
-
1,290
- Stock Symbol
-
01952
- Investments
-
2
- Share Price
-
$3.19
- (As of Tuesday Closing)
Everest Medicines General Information
Description
Everest Medicines Ltd is a biopharmaceutical company that integrates discovery, licensing, clinical development, commercialization, and manufacturing of potentially novel or differentiated therapies and vaccines to address critical unmet medical needs initially in the Asia Pacific markets and eventually around the world. Its product pipeline includes: Nefecon (TarpeyoTM), EVER001, Eravacycline (Xerava), SPR206, and others. Geographically operates in Mainland China.
Contact Information
Website
www.everestmedicines.comCorporate Office
- 17/F, AIA Financial Center
- 866 East Changzhi Road, Hongkou District
- Shanghai, 200082
- China
Corporate Office
- 17/F, AIA Financial Center
- 866 East Changzhi Road, Hongkou District
- Shanghai, 200082
- China
Everest Medicines Timeline
Everest Medicines Stock Performance
As of 17-Nov-2026, Everest Medicines’s stock price is $3.19. Its current market cap is $1.13B with 354M shares.
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $3.19 | $3.28 | $2.89 - $6.47 | $1.13B | 354M | 9.6M | -$0.02 |
Everest Medicines Financials Summary
As of 30-Jun-2026, Everest Medicines has a trailing 12-month revenue of $344M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 841,754 | 1,559,934 | 1,809,384 | 547,548 |
| Revenue | 344,186 | 237,325 | 98,485 | 17,800 |
| EBITDA | (28,158) | (67,283) | (136,685) | (120,468) |
| Net Income | (7,706) | (41,406) | (145,130) | (119,361) |
| Total Assets | 1,242,975 | 976,886 | 679,285 | 814,374 |
| Total Debt | 292,849 | 132,388 | 75,238 | 72,035 |
Everest Medicines Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Everest Medicines Comparisons
Industry
Financing
Details
Everest Medicines Competitors (1)
One of Everest Medicines’s competitors is Sumitomo Pharma (Pharmaceuticals), a Corporation company based in Mississauga, Canada.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sumitomo Pharma (Pharmaceuticals) | Corporation | Mississauga, Canada |
Everest Medicines Signals
Everest Medicines Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Everest Medicines Investments & Acquisitions (2)
Everest Medicines’s most recent deal was a Merger/Acquisition with Hasten Biopharmaceuticals (SG) for . The deal was made on 09-Apr-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Hasten Biopharmaceuticals (SG) | 09-Apr-2026 | Merger/Acquisition | Distributors/Wholesale | ||
| NovaBridge Biosciences | 05-Aug-2025 | PIPE | Drug Discovery |
Everest Medicines ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
38.13 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Everest Medicines FAQs
-
When was Everest Medicines founded?
Everest Medicines was founded in 2017.
-
Where is Everest Medicines headquartered?
Everest Medicines is headquartered in Shanghai, China.
-
What is the size of Everest Medicines?
Everest Medicines has 1,290 total employees.
-
What industry is Everest Medicines in?
Everest Medicines’s primary industry is Pharmaceuticals.
-
Is Everest Medicines a private or public company?
Everest Medicines is a Public company.
-
What is Everest Medicines’s stock symbol?
The ticker symbol for Everest Medicines is 01952.
-
What is the current stock price of Everest Medicines?
As of 17-Nov-2026 the stock price of Everest Medicines is $3.19.
-
What is the current market cap of Everest Medicines?
The current market capitalization of Everest Medicines is $1.13B.
-
What is Everest Medicines’s current revenue?
The trailing twelve month revenue for Everest Medicines is $344M.
-
Who are Everest Medicines’s competitors?
Sumitomo Pharma (Pharmaceuticals) is a competitor of Everest Medicines.
-
What is Everest Medicines’s annual earnings per share (EPS)?
Everest Medicines’s EPS for 12 months was -$0.02.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process